Publication of Final Terms
The following Final Terms are available for viewing:
Nationwide Building Society*
Final Terms dated 22 July 2024, relating to the issue by Nationwide Building Society of €1,000,000,000 Fixed-to-Floating Rate Senior Non-Preferred Notes due July 2032 issued pursuant to its U.S.$25,000,000,000 European Note Programme.
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/3471X_1-2024-7-22.pdf
A copy of the above document has also been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Nationwide Building Society
Sarah Abercrombie
Head of Investor Relations, Credit Ratings and Treasury Sustainability
Telephone: +44 (0) 7587 886500
Email: Sarah.Abercrombie@nationwide.co.uk
Nationwide Building Society
Nationwide House
Pipers Way
Swindon SN38 1NW
* LEI: 549300XFX12G42QIKN82
DISCLAIMER - INTENDED ADDRESSEES
EU MiFID II professionals/ECPs only/No EEA PRIIPs KID
UK MiFIR professionals/ECPs only/No UK PRIIPs KID
Please note that the information contained in the Base Prospectus dated 20 October 2023, as supplemented by the supplemental prospectuses dated 17 November 2023, 5 April 2024 and 23 May 2024 (together, the Base Prospectus) and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and are not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus and the Final Terms you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
